Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | Janus kinase 2 | Starlite/ChEMBL | No references |
Homo sapiens | Janus kinase 1 | Starlite/ChEMBL | No references |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | calpain family protein 1 | 0.013 | 0.9514 | 1 |
Trypanosoma cruzi | calpain cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma brucei | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | calpain, putative | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | calpain, putative | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | calpain-like protein, putative | 0.0049 | 0.2831 | 1 |
Schistosoma mansoni | Mername-AA248 (C02 family) | 0.0049 | 0.2831 | 0.2831 |
Loa Loa (eye worm) | calpain 5 | 0.0034 | 0.1614 | 0.1697 |
Schistosoma mansoni | calpain C (C02 family) | 0.0049 | 0.2831 | 0.2831 |
Onchocerca volvulus | 0.0081 | 0.5466 | 0.5 | |
Loa Loa (eye worm) | calpain | 0.0049 | 0.2831 | 0.2976 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Brugia malayi | calpain family protein 1 | 0.013 | 0.9514 | 1 |
Trypanosoma brucei | antigen, putative | 0.0049 | 0.2831 | 1 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Echinococcus multilocularis | calpain family protein 1, d | 0.0096 | 0.6683 | 0.5373 |
Brugia malayi | calpain 5 | 0.0034 | 0.1614 | 0.1697 |
Trypanosoma cruzi | kinesin, putative | 0.0034 | 0.1614 | 0.5701 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0136 | 1 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.013 | 0.9514 | 0.9514 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Loa Loa (eye worm) | calpain family protein 1 | 0.0096 | 0.6683 | 0.7024 |
Toxoplasma gondii | hypothetical protein | 0.0015 | 0 | 0.5 |
Trypanosoma brucei | kinesin, putative | 0.0034 | 0.1614 | 0.5701 |
Entamoeba histolytica | protein kinase, putative | 0.0034 | 0.1614 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.0049 | 0.2831 | 1 |
Brugia malayi | calpain family protein 1 | 0.013 | 0.9514 | 1 |
Echinococcus multilocularis | family C2 unassigned peptidase (C02 family) | 0.0136 | 1 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Echinococcus granulosus | family C2 unassigned peptidase C02 family | 0.0136 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | calpain (C02 family) | 0.0049 | 0.2831 | 0.2831 |
Trypanosoma brucei | cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Leishmania major | kinesin, putative | 0.0034 | 0.1614 | 0.5701 |
Trypanosoma brucei | calpain-like protein, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma cruzi | kinesin, putative | 0.0034 | 0.1614 | 0.5701 |
Plasmodium falciparum | calpain | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.013 | 0.9514 | 1 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.0049 | 0.2831 | 0.2831 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.8297 | 0.8721 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Brugia malayi | calpain 7 | 0.0049 | 0.2831 | 0.2976 |
Toxoplasma gondii | calpain family cysteine protease domain-containing protein | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | calpain, putative | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Trypanosoma cruzi | calpain-like cysteine peptidase, putative | 0.0049 | 0.2831 | 1 |
Plasmodium vivax | calpain, putative | 0.0049 | 0.2831 | 0.5 |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Trypanosoma brucei | calpain-like protein, putative | 0.0049 | 0.2831 | 1 |
Entamoeba histolytica | calpain large subunit domain III containing protein | 0.0034 | 0.1614 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0015 | 0 | 0.5 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0096 | 0.6683 | 0.7024 |
Trichomonas vaginalis | Clan CA, family C2, calpain-like cysteine peptidase | 0.0015 | 0 | 0.5 |
Schistosoma mansoni | calpain-7 (C02 family) | 0.0049 | 0.2831 | 0.2831 |
Echinococcus multilocularis | calpain A | 0.0136 | 1 | 1 |
Trypanosoma cruzi | cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Leishmania major | calpain, putative,cysteine peptidase, Clan CA, family C2, putative | 0.0049 | 0.2831 | 1 |
Schistosoma mansoni | family C2 unassigned peptidase (C02 family) | 0.0136 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.5466 | 0.5745 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 11 nM | BindingDB_Patents: HTRF Assay. The ability of compounds to inhibit the activity of JAK1, JAK2, JAK3, and Tyk2 was measured using a recombinant purified GST-tagged catalytic domain for each enzyme (Invitrogen JAK1 #M4290, JAK2 #M4290, JAK3 #M4290, Tyk2 #M4290) in an HTRF format biochemical assay. The reactions employed a common peptide substrate, LCB-EQEDEPEGDYFEWLW-NH2 (in-house). The basic assay protocol is as follows: First, 250 mL of diluted compounds in DMSO were dispensed into the wells of a dry 384-well Black plate (Greiner #781076) using a Labcyte Echo 555 acoustic dispenser. Subsequent reagent additions employed an Agilent Bravo. Next, 18 uL of 1.11x enzyme and 1.11x substrate in 1x assay buffer (Invitrogen kinase buffer #PV3189, 2 mM DTT, 0.05% BSA) were added to the wells and shaken and then preincubated for 30 minutes at ambient temperature to allow compound binding to equilibrate. After equilibration, 2 uL of 10xATP in 1x assay buffer was added to initiate the kinase reaction. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.